Global Blood Bags Market, By Product (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), Type (Collection Bag, Transfer Bag), Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), Material (PVC, PET, Others), End-User (Hospitals, Clinics, Ambulatory Surgical Center, Blood Banks, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
The global blood bags market is expected to witness significant growth during the forecast period. The blood bag system is a disposable biomedical device designed to collect, store, transport, and transmit human blood and blood-derived products. Disposable blood bags are used by hospitals, blood banks, government programs, and non-governmental agencies (NGOs) collected during blood donation programs. The blood bag market is expected to grow as the use of blood bags for storage, transportation and blood transfusions increases. The growing demand for sterility in the transfusion, transportation and storage of blood and its constituents has increased the demand for blood bags.
Data Bridge Market Research analyses a growth rate in the global blood bags market in the forecast period 2022-2029. The expected CAGR of global blood bags market is tend to be around 9.40% in the mentioned forecast period. The market was valued at USD 241.88 million in 2021, and it would grow upto USD 496.29 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
The blood bags are a kind of flexible small pouches that are used for storing, collecting, transfusion, and transporting blood along with different blood components such as RBC, WBC, and blood platelets. The blood and its components are stored in the blood bags. The blood bags are required to store blood and its components as the blood are very sensitive to temperature, light, and air.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Million, Volumes in Units, Pricing in USD
By Product (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), Type (Collection Bag, Transfer Bag), Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), Material (PVC, PET, Others), End-User (Hospitals, Clinics, Ambulatory Surgical Center, Blood Banks, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
TERUMO BCT, INC. (U.S.), Macopharma (France), Fresenius Kabi India Pvt. Ltd (India), Grifols, S.A. (Spain), Neomedic International SL (U.K.), Teleflex Incorporated (U.S.) Qingdao Sinoland International Trade Co.,Ltd (China), JMS Co.Ltd (Japan), Demophorius Healthcare Ltd (Greece), KAWASUMI LABORATORIES. INC. (Japan), Polymedicure (India), AdvaCare Pharma (China), Coloplast Corp (Denmark), Innvol. (India), The Metrix Company. (U.S.), BL Lifesciences. (India), SURU INTERNATIONAL PVT. LTD (India)
Global Blood Bags Market Dynamics
- Increasing road-traffic related crashes
According to a World Health Organization (WHO) report (2020), about 1.35 million people die each year in road accidents. About 20 to 50 million people have non-fatal injuries, many of whom have disabilities due to the injuries. About 93% of the world's road deaths occur in low- and middle-income countries, which account for about 60% of the world's automobiles. Even in high-income countries, people with low socio-economic backgrounds are more likely to be involved in a road accident. Therefore, an increase in road accidents can lead to blood loss injuries and boost market growth.
- Increase in blood donation camps
Increasing numbers of blood donation camps and plasma collections around the world will lead to increased use of disposable blood bags. This is an important factor driving the growth of the blood bag market.
- Increasing government initiatives
Government-funded initiatives in various Asian countries focus on developing blood separation techniques to reduce imports of blood components from developed countries. In addition, government initiatives are supporting voluntary blood sampling activities, increasing the demand for blood bags in the region.
- Increased blood collection initiatives
The high number of blood collection initiatives associated with blood collection bags is expected to increase the importance of high-income countries. The collected blood can be used to collect blood components such as platelets and plasma, and the market for blood bags is expected to expand in the future.
- Lack of skilled professionals
The lack of manpower for using these blood bags could curb the growth of the global blood bags market over a forecast period.
- High Cost
High cost of these blood bags can hinder the growth of the global blood bags market even though the prevalence of the co-morbid conditions are high.
This global blood bags market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global blood bags market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Blood Bags Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
In the COVID-19 pandemic, passive immunotherapy with whole blood or plasma of recovered patients is a potential infection strategy. The process of transfusing neutralizing antibodies through convalescent blood is a strategy used in hospitals around the world. Therefore, the rapid adoption of blood and plasma immunotherapy is increasing the use of blood bags and is expected to drive market growth over the forecast period. Therefore, the high risks associated with blood donations and blood transfusions are hindering market growth.
Global Blood Bags Market Scope
The blood bags market is segmented on the basis of product, type, volume, material and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Single Blood Bag
- Double Blood Bag
- Triple Blood Bag
- Quadruple Blood Bag
- Penta Blood Bag
- Collection Bag
- Transfer Bag
- Ambulatory Surgical Center
- Blood Banks
Blood Bags Market Regional Analysis/Insights
The global blood bags market is analysed and market size insights and trends are provided by type, technology, image and indications as referenced above.
The major countries covered in the global blood bags market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America will dominate the blood bags market due to the rising number of research and development activities, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the development of the healthcare sector along with rising awareness among the people regarding blood donation and its benefits.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Blood Bags Market Share Analysis
The global blood bags market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to blood bags market.
Key players operating in the global blood bags market include:
- TERUMO BCT, INC. (U.S.)
- Maco Pharma (France)
- Fresenius Kabi India Pvt. Ltd (India)
- Grifols, S.A. (Spain)
- Neomedic International SL (U.K.)
- Teleflex Incorporated (U.S.)
- Qingdao Sinoland International Trade Co.,Ltd (China)
- JMS Co.Ltd (Japan)
- Demophorius Healthcare Ltd (Greece)
- KAWASUMI LABORATORIES. INC. (Japan)
- Polymedicure (India)
- AdvaCare Pharma (China)
- Coloplast Corp (Denmark)
- Innvol. (India)
- The Metrix Company. (U.S.)
- BL Lifesciences. (India)
- SURU INTERNATIONAL PVT. LTD (India)